Studies have shown that activation of the TLR4/NF‐κB inflammatory pathway can cause vascular dysfunction in hypertension, and inhibition of this pathway can effectively improve vascular function.4, 5, 6, 7. Here, TLR4 is linked to hypertensive disorder.